1. Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management
    Georgia Ι. Grigoriadou et al, 2020, Journal of Personalized Medicine CrossRef
  2. ALK and ROS1 testing on lung cancer cytologic samples: Perspectives
    Pasquale Pisapia et al, 2017, Cancer Cytopathology CrossRef
  3. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project
    Jacek Niklinski et al, 2017, Advances in Medical Sciences CrossRef
  4. Limited effect of afatinib in a non‐small cell lung cancer patient harboring an epidermal growth factor receptor K860I missense mutation: A case report
    Tomoki Tamura et al, 2021, Thoracic Cancer CrossRef
  5. Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk
    Yagmur Kan et al, 2023, Biochemistry CrossRef
  6. Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare
    Jun Yasuda et al, 2019, The Journal of Biochemistry CrossRef
  7. Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis
    Tian-tian Li et al, 2018, Pathology - Research and Practice CrossRef
  8. Evaluation of Light's criteria in cytologically proved malignant pleural effusions
    Samuel GARCIA-REINA et al, 2023, Minerva Medica CrossRef
  9. Comparison between Immunocytochemistry, FISH and NGS for ALK and ROS1 Rearrangement Detection in Cytological Samples
    Diane Frankel et al, 2022, International Journal of Molecular Sciences CrossRef
  10. Genetic Biomarkers and Their Applications to Prevent Occupational Diseases: A Literature Review
    Kyung-Taek Rim, 2018, Toxicology and Environmental Health Sciences CrossRef
  11. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram
    R. Li et al, 2022, Clinical Radiology CrossRef
  12. Next Generation Sequencing Technology in Lung Cancer Diagnosis
    Calin Cainap et al, 2021, Biology CrossRef
  13. Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape
    Anurag Mehta et al, 2020, Applied Cancer Research CrossRef
  14. Lung Cancer
    Katalin Dobra et al, 2018, Serous Effusions CrossRef
  15. Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    Filiz Oezkan et al, 2018, Clinical Lung Cancer CrossRef